Thorsten Mende

1.2k total citations · 1 hit paper
9 papers, 904 citations indexed

About

Thorsten Mende is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Thorsten Mende has authored 9 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Thorsten Mende's work include Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). Thorsten Mende is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). Thorsten Mende collaborates with scholars based in Germany and United States. Thorsten Mende's co-authors include Dieter K. Hossfeld, Walter Fiedler, Nerbil Kilic, Gunter Schuch, Ursula M. Gehling, Birgit Schäfer, Süleyman Ergün, Klaus Pantel, Christoph Wagener and Philippe Schafhausen and has published in prestigious journals such as Blood, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Thorsten Mende

9 papers receiving 878 citations

Hit Papers

In vitro differentiation of endothelial cells from AC133-... 2000 2026 2008 2017 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thorsten Mende Germany 6 667 274 236 167 160 9 904
K Kluge Germany 5 660 1.0× 236 0.9× 234 1.0× 167 1.0× 159 1.0× 7 902
Marcus Otte Germany 8 807 1.2× 339 1.2× 236 1.0× 170 1.0× 230 1.4× 10 1.2k
Steven M. Guthrie United States 13 707 1.1× 229 0.8× 333 1.4× 157 0.9× 141 0.9× 16 1.2k
Ichiro Onitsuka Japan 4 549 0.8× 116 0.4× 268 1.1× 227 1.4× 128 0.8× 6 809
Alessia Orlandi Italy 7 542 0.8× 188 0.7× 252 1.1× 207 1.2× 145 0.9× 9 885
Rachel Krasich United States 5 941 1.4× 223 0.8× 278 1.2× 216 1.3× 202 1.3× 5 1.2k
Choon-Soo Lee South Korea 12 944 1.4× 193 0.7× 247 1.0× 257 1.5× 174 1.1× 16 1.3k
Cheryl O. Quinn United States 15 724 1.1× 363 1.3× 340 1.4× 173 1.0× 239 1.5× 21 1.3k
Anna Rita Torella Italy 6 444 0.7× 164 0.6× 226 1.0× 180 1.1× 122 0.8× 8 714
Julia Asp Sweden 18 658 1.0× 180 0.7× 147 0.6× 270 1.6× 151 0.9× 49 1.3k

Countries citing papers authored by Thorsten Mende

Since Specialization
Citations

This map shows the geographic impact of Thorsten Mende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Mende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Mende more than expected).

Fields of papers citing papers by Thorsten Mende

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Mende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Mende. The network helps show where Thorsten Mende may publish in the future.

Co-authorship network of co-authors of Thorsten Mende

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten Mende. A scholar is included among the top collaborators of Thorsten Mende based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten Mende. Thorsten Mende is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Laack, Eckart, Thorsten Mende, Heinz Dürk, et al.. (2002). Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer. European Journal of Cancer. 38(5). 654–660. 7 indexed citations
2.
Laack, Eckart, Thorsten Mende, A. Chemaissani, et al.. (2001). Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer. European Journal of Cancer. 37(5). 583–590. 27 indexed citations
3.
Laack, Eckart, et al.. (2001). Hand–foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine. Annals of Oncology. 12(12). 1761–1763. 11 indexed citations
4.
Fiedler, Walter, William Krüger, Eckart Laack, et al.. (2001). A clinical trial of edrecolomab, interleukin-2 and GM-CSF in patients with advanced colorectal cancer. Oncology Reports. 8(2). 225–31. 8 indexed citations
5.
Gehling, Ursula M., Süleyman Ergün, Udo Schumacher, et al.. (2000). In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 95(10). 3106–3112. 795 indexed citations breakdown →
6.
Gehling, Ursula M., Süleyman Ergün, Udo Schumacher, et al.. (2000). In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 95(10). 3106–3112. 50 indexed citations
7.
Laack, Eckart, Thorsten Mende, A. Chemaissani, et al.. (1999). A multicenter phase II trial with gemcitabine (GEM) and vinorelbine (VNR) in the treatment of non-small cell lung cancer (NSCLC) stage IIIB and IV. European Journal of Cancer. 35. S252–S252. 1 indexed citations
8.
Mende, Thorsten, et al.. (1965). A Study of Total Body Protein Turnover in Rats of Different Ages. Gerontology. 11(3-4). 208–213. 4 indexed citations
9.
Mende, Thorsten. (1965). Studies on Cr<sup>5</sup><sup>1</sup> Labeled Erythrocyte Turnover in Relation to Age. Gerontology. 11(1-2). 57–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026